BPL Medical Technologies made a strong impact at the 78th Annual Conference of the diagnostics, and women’s health technologies...
Healthcare major Cupid Limited has secured CE certification for its HIV 1&2 and Hepatitis B test kits under EU IVDR, unlocking access to regulated European and global diagnostics markets.
RPG Life Sciences supports the India–EU FTA, highlighting the tariff reduction on pharmaceuticals. The move boosts India's pharma competitiveness, global exports, and access to affordable medicines.
India’s India-EU FTA opens access to a $572.3 billion pharma and MedTech market, cutting tariffs and boosting exports, jobs, and manufacturing across key Indian states.
Panchkula-based Venus Remedies has received its second PLI incentive payout for FY25, taking total disbursements to 75%. The release follows the company meeting investment, production, and sales targets under the scheme.
Akums Drugs secures EU GMP renewal for Plant 1 and first-time approval for Plant 2 in Haridwar, boosting its global CDMO presence in regulated pharma markets.
Corona Remedies Limited has secured the Eurasian Economic Union – Good Manufacturing Practices (EAEU–GMP) certification, marking a significant milestone in its global expansion. Announced on January 22, 2026, this certification allows the compa...
Max Institute of Laparoscopic Surgery, Robotic Surgery, Bariatric Surgery & GI Surgery has entered into a strategic Memorandum of Understanding (MoU) with Intuitive Surgical to accelerate the adoption of robotic-assisted surgery in India. The part...
AstraZeneca has acquired AbelZeta Pharma’s remaining China rights to the CAR-T therapy C-CAR031, gaining full global control while positioning the program for broader development in liver cancer and solid tumors.
Manthan 2026, a Research & Development Leadership Symposium, concluded successfully at Novotel, Mumbai. The insightful day-long symposium brought together eminent voices, leaders, and experts from across India’s life sciences and clinical...